Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Avandia 8mg tablets
0601023S0BBABAB
|
Avandia | Rosiglitazone | Endocrine System | No data available |
|
Avastin 100mg/4ml solution for infusion vials
0801050APBBAAAA
|
Avastin | Bevacizumab | Malignant Disease and Immunosuppression | No data available |
|
Avastin 400mg/16ml solution for infusion vials
0801050APBBABAB
|
Avastin | Bevacizumab | Malignant Disease and Immunosuppression | No data available |
|
Aveeno baby bath additive colloidal powder 15g sachets
130201100BBATA0
|
Proprietary compound preparation BNF 1302011 | Emollient bath and shower preparations | Skin | No data available |
|
Aveeno bath additive colloidal powder 50g sachets
130201100BBARA0
|
Proprietary compound preparation BNF 1302011 | Emollient bath and shower preparations | Skin | No data available |
|
Avelle dressing 12cm x 31cm
20032100127
|
Avelle dressing 12cm x 31cm | Wound Management & Other Dressings | Dressings | No data available |
|
Avelle dressing 12cm x 41cm
20032100149
|
Avelle dressing 12cm x 41cm | Wound Management & Other Dressings | Dressings | No data available |
|
Avelle dressing 21cm x 26cm
20032100150
|
Avelle dressing 21cm x 26cm | Wound Management & Other Dressings | Dressings | No data available |
|
Avelle dressing 26cm x 26cm
20032100151
|
Avelle dressing 26cm x 26cm | Wound Management & Other Dressings | Dressings | No data available |
|
Avelox 400mg/250ml solution for infusion bottles
0501120Y0BBABAB
|
Avelox | Moxifloxacin | Infections | No data available |
|
Avelox I.V. 400mg/250ml infusion bags
0501120Y0BBACAC
|
Avelox | Moxifloxacin | Infections | No data available |
|
Avelumab 200mg/10ml solution for infusion vials
0801050CFAAAAAA
|
Avelumab | Avelumab | Malignant Disease and Immunosuppression | No data available |
|
Aviral 5% cream
1310030C0BIAAAA
|
Aviral | Aciclovir | Skin | No data available |
|
AVITA BPC Vitamin capsules
0906070T0BEAAAA
|
AVITA | Vitamins caps | Nutrition and Blood | No data available |
|
Avonex 30microgram inj vials
0802040M0BDAAAE
|
Avonex | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Avonex 30micrograms/0.5ml (6million units) inj pf pens
0802040M0BDACAM
|
Avonex | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Avonex 30micrograms/0.5ml (6million units) inj pfs
0802040M0BDABAF
|
Avonex | Interferon beta | Malignant Disease and Immunosuppression | No data available |
|
Axid 100mg/4ml solution for infusion ampoules
0103010N0BBACAC
|
Axid | Nizatidine | Gastro-Intestinal System | No data available |
|
Axid 150mg capsules
0103010N0BBAAAA
|
Axid | Nizatidine | Gastro-Intestinal System | No data available |
|
Axid 300mg capsules
0103010N0BBABAB
|
Axid | Nizatidine | Gastro-Intestinal System | No data available |
|
Axitinib 1mg tablets
0801050BJAAAAAA
|
Axitinib | Axitinib | Malignant Disease and Immunosuppression | No data available |
|
Axitinib 3mg tablets
0801050BJAAADAD
|
Axitinib | Axitinib | Malignant Disease and Immunosuppression | No data available |
|
Axitinib 5mg tablets
0801050BJAAABAB
|
Axitinib | Axitinib | Malignant Disease and Immunosuppression | No data available |
|
Axitinib 7mg tablets
0801050BJAAACAC
|
Axitinib | Axitinib | Malignant Disease and Immunosuppression | No data available |
|
Axorid 100mg/20mg modified-release capsules
1001010L0BQAAAM
|
Axorid | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.